BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer

/PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced that it has...

Related Keywords

Jerusalem ,Israel General ,Israel ,United States ,Russia ,Ukraine ,Russian ,Moran Meir ,John Lacey ,Tami Rachmilewitz ,Philip Serlin ,Neuroderm Ltd ,Hadassah Medical School ,Lifesci Advisors ,Exchange Commission On ,Nasdaq ,Novartis ,Biolinerx Ltd ,Teva Pharmaceutical Industries Ltd ,Prnewswire Biolinerx Ltd ,Bachelor Of Medical Sciences ,Hebrew University Of Jerusalem ,Years Of Clinical Development Industry Knowledge ,Clinical Development ,Experienced Drug Developer Brings Over ,Clinical Development Industry Knowledge ,Multiple Therapeutic Areas ,Chief Medical ,Chief Executive Officer ,Chief Medical Officer ,Senior Vice President ,Medical Sciences ,Hebrew University ,Private Securities Litigation Reform Act ,Exchange Commission ,Sci Advisors ,Biolinerx ,